Covidien is planning to bring its Duet TRS surgical stapling system back to the U.S. market in about a year, CEO Joe Almeida said during the firm’s Aug. 1 fiscal 2013 third-quarter earnings call.
“We are working now with the FDA and we probably are looking into another 12 months in terms of filings...